Effect of Rosiglitazone on Bone Metabolism
A three month randomised, double-blind, placebo-controlled trial to determine the effect of rosiglitazone on bone and calcium metabolism in normal post menopausal women.
Associate Professor A Grey
50 participants
Sep 1, 2004
Interventional
Conditions
Summary
This is a 3 month study designed to determine the effect of rosiglitazone on bone metabolism
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
8mg rosiglitazone daily over 3 months
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000218695